rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
24
|
pubmed:dateCreated |
1999-5-26
|
pubmed:abstractText |
The aim of this study was to investigate the IFN-inhibiting activity in sera from patients with gastrointestinal malignancies, exerted in a variety of cellular types, as well as to elucidate the determinants of cellular sensitivity to such IFN-inhibitors.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0172-6390
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2244-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9951903-Aged,
pubmed-meshheading:9951903-Aged, 80 and over,
pubmed-meshheading:9951903-Cell Line,
pubmed-meshheading:9951903-Colonic Neoplasms,
pubmed-meshheading:9951903-Female,
pubmed-meshheading:9951903-Humans,
pubmed-meshheading:9951903-Interferons,
pubmed-meshheading:9951903-Male,
pubmed-meshheading:9951903-Middle Aged,
pubmed-meshheading:9951903-Reference Values,
pubmed-meshheading:9951903-Stomach Neoplasms
|
pubmed:articleTitle |
Detection of interferon inhibitors or antagonists in gastrointestinal malignancies.
|
pubmed:affiliation |
3rd Department of Internal Medicine, NIMTS Hospital, Athens, Greece.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|